INVL Group completed the first closing of its second-generation private equity fund, INVL Private Equity Fund II, raising €305m and surpassing its initial €250m target.

The fund is now the largest private equity vehicle in the Baltics and will invest across Lithuania, Latvia, Estonia, Poland, Romania, and the broader EU, targeting companies with strong growth potential.

Morphosis Capital launched its second fund, Morphosis Capital Fund II, securing over €100m in committed capital—double the size of its predecessor.

The Romania-based private equity firm aims to invest in SMEs across Romania and neighbouring regions, targeting sectors such as healthcare, B2B services, consumer products and retail, and niche manufacturing.

Read more here.

MidEuropa-backed Diagnostyka, a leading Polish diagnostic service provider, made its stock market debut on 7 February 2025, achieving a valuation of over €1bn.

The IPO stands among the largest private equity-backed public exits in recent years.

Priced at PLN105 (€25) per share, the listing raised more than €400m in gross proceeds for MidEuropa’s investors, marking the firm’s full exit after more than a decade. Since acquiring Diagnostyka in 2011, MidEuropa has fueled its growth through 120 acquisitions, reinforcing its dominance in European healthcare.